Precision BioSciences Inc (STU:PBS0)
€ 7.7 -0.05 (-0.65%) Market Cap: 59.55 Mil Enterprise Value: -6.13 Mil PE Ratio: 140.33 PB Ratio: 0.97 GF Score: 38/100

Precision BioSciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:00PM GMT
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Good afternoon, and thanks for tuning in to the JPMorgan Health Care Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company is Precision BioSciences. And here to talk to us a little bit about the company is CEO, Matt Kane.

Before I hand the presentation over to him, let me just remind folks that there is a Q&A after the presentation. (Operator Instructions)

With that, Matt, thanks for sharing some of your time with us this afternoon.

Matthew R. Kane
Precision BioSciences, Inc. - Co-Founder, CEO, President & Director

Yes. No, thanks, Eric, and it's great to be with you again, and everybody that's on the line today. Since we're in this virtually, I'm going to try to guide us through the deck.

So let's turn to Slide 2. Before we begin, I've got to remind everyone that the statements we make may be considered forward-looking. And so please refer to our most recent 10-Q for more information about our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot